137 related articles for article (PubMed ID: 8631002)
21. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
[TBL] [Abstract][Full Text] [Related]
22. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer.
Shridhar V; Staub J; Huntley B; Cliby W; Jenkins R; Pass HI; Hartmann L; Smith DI
Oncogene; 1999 Jul; 18(26):3913-8. PubMed ID: 10445856
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
[TBL] [Abstract][Full Text] [Related]
24. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
27. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
28. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
29. Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27.
Saito S; Sirahama S; Matsushima M; Suzuki M; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1996 Dec; 56(24):5586-9. PubMed ID: 8971159
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of proximal 6q deletions in prostate cancer.
Cooney KA; Wetzel JC; Consolino CM; Wojno KJ
Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584
[TBL] [Abstract][Full Text] [Related]
31. Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer.
Nagase S; Yamakawa H; Sato S; Yajima A; Horii A
Cancer Res; 1997 May; 57(9):1630-3. PubMed ID: 9134997
[TBL] [Abstract][Full Text] [Related]
32. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
[TBL] [Abstract][Full Text] [Related]
33. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
35. Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers.
Saito S; Saito H; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1992 Oct; 52(20):5815-7. PubMed ID: 1394208
[TBL] [Abstract][Full Text] [Related]
36. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
[TBL] [Abstract][Full Text] [Related]
37. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
38. [Localization of a tumor suppressor gene distal to D22S270 in colorectal cancers].
Duriez C; Schmitz A; Fouchet P; Buecher B; Thuille B; Lerebours F; Léger R; Boman F; Fléjou JF; Monges G; Paraf F; Bedossa P; Sabourin JC; Salmon RJ; Laurent-Puig P; Thomas G; Olschwang S
Gastroenterol Clin Biol; 1997; 21(5):358-64. PubMed ID: 9208010
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
[TBL] [Abstract][Full Text] [Related]
40. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
